-- 根據FactSet調查的分析師報告，Merit Medical Systems (MMSI) 的平均評級為“增持”，平均目標價為90.64美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Price: $64.78, Change: $-3.40, Percent Change: -4.98%
Related Articles
Australia
Argus Adjusts Price Target on Nasdaq to $103 From $98
Nasdaq (NDAQ) has an average rating of buy and mean price target of $110.06, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $91.54, Change: $-0.37, Percent Change: -0.40%
$NDAQ
Australia
Argus Adjusts Price Target on IDEX to $250 From $240
IDEX (IEX) has an average rating of overweight and mean price target of $236.46, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $214.86, Change: $-2.99, Percent Change: -1.37%
$IEX
Australia
Argus Adjusts Price Target on Thermo Fisher Scientific to $560 From $610
Thermo Fisher Scientific (TMO) has an average rating of buy and mean price target of $623.48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $470.05, Change: $-8.91, Percent Change: -1.86%
$TMO